Topo I, topoisomerase I; p91, human topo I (amino acids 1-765); p67, human topo I (amino acids 207-765); p25, human topo I (amino acids 1-218); DTT, dithiothreitol; BSA, bovine serum albumin; DMSO, dimethyl sulfoxide; PMSF, phenylmethylsulfonyl fluoride; GST, glutathione S-transferase; IPTG, isopropyl β-D-thiogalactopyranoside; PBS, phosphate-buffered saline; TBE, Tris-Borate electrophoresis buffer; dApdG, 2'-deoxyadenylyl(3'->5')-2'-deoxyguanosine. 
INTRODUCTION
Eukaryotic topoisomerase I (topo I) is a monomeric enzyme that plays a major role in important cellular processes by regulating the topology of DNA. The enzyme relaxes negative and positive supercoils arising as a consequence of DNA processes such as DNA transcription, replication, recombination, and chromosome condensation (1) .
Mechanistically, topo I acts by introducing transient single-strand breaks into the DNA double helix. The catalytic cycle can be subdivided into several steps including: i) non-covalent DNA binding, ii) cleavage, iii) strand rotation, iv) religation, and v) enzyme turnover. The cleavage and religation events constitute two reverse phosphoryl transfer (transesterification) reactions. During the cleavage reaction, an active site tyrosine residue of the enzyme is used as a nucleophile to break a phosphodiester bond of the DNA backbone, generating a covalent enzyme-(3´-phosphotyrosyl)-DNA linkage and a free 5´-hydroxyl group (2) (3) (4) . This 5´-hydroxyl group provides the nucleophile for the religation reaction that restores intact DNA. , Arg 590 and His 632 of the core domain constitutes the active site of the enzyme (4) (5) (6) (7) (8) . Structural data show that the core and C-terminal domains form a clamp structure that wraps around the DNA, and together with the helix-turn-helix linker domain
(1) contacts DNA in a region extending 4 basepairs upstream and 9 basepairs downstream of the cleavage site (3) . Based on this structural information of the human topo I-DNA complex, a model for strand rotation (topoisomerization) has been proposed. According to this "controlled rotation" model, rotation of the cleaved strand around the intact strand is partially hindered by contacts between the rotating DNA and part of the core and linker domains (3) . The involvement of the linker in controlling strand rotation has recently been supported by biochemical studies
showing that the sensitivity of topo I towards camptothecin in relaxation depends on a functional linker domain (9) . The recently published crystal structure of a topo I form encompassing a few residues of the N-terminal domain (amino acids 203 to 214) demonstrate an interaction between
Trp205 and the hinge region of the core domain (37) . This interaction has been proposed to be important for the flexibility of the enzyme clamp allowing controlled strand-rotation. Beside such speculations the putative enzymatic function(s) of the N-terminal domain of topo I has remained unknown. Based on biochemical analyses, it is assumed to be largely unfolded or highly dynamic (2, 10) . It is essential for nuclear localization of topo I and four nuclear localization signals have been identified within the domain (11) . For years it has been considered unimportant for catalysis, since the first purified forms of catalytically active topo I were in fact proteolytic degradations products lacking this domain (12, 13) . The apparent dispensability of the N-terminal domain was recently supported by deletion studies showing that human topo I variants lacking either the first 174 (9) or the first 190 amino acids (14) show no obvious defects in vitro.
In the present work we have addressed the possible role of the N-terminal domain in topo I catalysis by comparing the in vitro activities of a truncated version of human topo I lacking amino acids 1-206 (p67) with those of the full-length enzyme (p91). We have found significant differences between p67 and p91 in DNA binding, cleavage, strand rotation and ligation. The sum of our results held together with previous reports showing no effect of deleting the first 190 amino acids of the enzyme (14) suggests a particularly important role of amino acids 191 to 206 of the N-terminal domain in catalysis most probably by coordinating non-covalent enzyme-DNA interactions during the individual steps of topoisomerization. human topo I (p91) in S. cerevisiae was described previously (16) . Plasmid pHT148 for expression of a fusion of GST to the N-terminus of amino acids 207-765 of human topo I (GSTp67) was constructed by first cloning a PCR fragment of pGEX-2TK containing the GST-tag and the polylinker into a BamHI/EcoRI fragment of pHT143. The original BamHI site in pHT143 was destroyed and the topo I gene deleted from pHT143 by this cloning step, generating a new cloning vector referred to as pRS426-GAL-GST. Subsequently, a PCR fragment containing amino acids 207-765 of human topo I was cloned into a BamHI/EcoRI fragment of pRS426-GAL-GST generating pHT148. pHT147 for expression of a GST-tagged N-terminal fragment (p25) of human topo I was constructed by inserting a PCR fragment encoding amino acids 1-218 of topo I into the BamHI/EcoRI site of the pGEX-2TK vector. In the pHT148 and pHT147
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constructs, the GST-tag and the topo I fragments were separated by specific cleavage at a thrombin protease site (see below).
Expression and purification of recombinant forms of human topo I. The plasmids pHT143 and pHT148 for expression of p91 and GST-p67, respectively, were transformed into the yeast S.
cerevisiae strain RS190. Crude cell extracts from 12 liters of yeast culture expressing the p91 or GST-p67 were prepared and the proteins were purified on two heparin sepharose columns and a phenyl sepharose column essentially as described previously (17) . For purification of p67 the GST tag was cleaved off by thrombin (see below) before applying the protein preparations on the phenyl sepharose column. For comparability, p91 was subjected to this procedure too, but leaving out the thrombin protease. The purified enzymes were concentrated and the buffers exchanged on a 0.5 ml Source 15S column. In the final step, p67 and p91 were eluted with a buffer containing 600 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 10% glycerol. A
GST-tagged N-terminal fragment of human topo I, GST-p25, was expressed from the plasmid pHT147 in the bacterial strain BL21 (18) . Bacteria were grown at 37 Û& LQ PO /% PHGLXP containing 0.1 mg/ml ampicillin until OD600 had reached 0.6. Expression of GST-p25 was ice and cell debris subsequently eliminated by centrifugation for 5 min at 14.000 rpm. The supernatant was loaded onto a 2 ml prepacked glutathione-sepharose column by gravity flow and the column subsequently washed with 20 ml of ice-cold 1xPBS. Before eluting p25 in 500 mM NaCl, 10 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 10% glycerol, 15 units of thrombin protease was dissolved in 1.5 ml 1xPBS and loaded onto the column, which was then sealed and incubated overnight at room temperature. Homogeneity of the p25 preparation was obtained on a 100 µl Source 15S column as described above for p67 and p100. An equal volume of 87% glycerol was added to the enzyme preparations before storage at -20°C. Protein preparations were analyzed by SDS-PAGE. Following coomassie staining, the intensities of the protein bands were compared to a dilution series of a BSA standard in order to determine the protein concentrations.
Thrombin cleavage. In a standard digestion, 1 mg of GST-p67 was incubated with 150 units of thrombin for 1 hour at room temperature in an 8 ml volume of 1xPBS containing 5 mM DTT.
Subsequently, the digestion mixture was diluted to 50 ml with 1xPBS and passed over a 2 ml prepacked glutathione-sepharose column three times in order to remove uncleaved fusion protein and liberated GST-tag. The N-terminal amino acid sequence of p67 after thrombin cleavage was The cleavage reactions were stopped by addition of NaCl to a final concentration of 375 mM and cleavage products analyzed on an 8% SDS Tris-Glycine polyacrylamide gel.
Topo I mediated ligation. Active topo I-DNA cleavage complexes containing the enzyme covalently attached at an internal (using DNA substrate OL19/OL27) or a terminal (using DNA substrate OL22/OL25) position were generated by pre-incubating 50 fmol of suicide DNA substrate with 500 fmol of topo I at 37°C for 5 minutes. This reaction was performed as described for topo I mediated cleavage and terminated by addition of 300 mM NaCl. 
RESULTS
DNA Relaxation activity of p67 and p91.
To investigate the effects on enzymatic activity of deleting the N-terminal domain of human topo I, recombinant p67 (amino acids 207-765) and p91 (amino acids 1-765) were purified from yeast (see Fig. 1 ) and assayed for DNA relaxation activity. Two sets of time course experiments were performed in a low salt buffer (5 mM MgCl 2 )
at 37°C. In the first set, with a 3-fold molar excess of plasmid DNA compared to enzyme, p67
relaxed supercoiled pBR322 16-64 times faster than p91 ( Fig. 2A) . In the second set, with the enzyme concentration increased to a 2-fold molar excess compared to plasmid substrate, the relaxation rate of p67 was slower than that of p91 (compare lanes 2 and 8 in Fig. 2B ). Thus, the relative activity of p67 with respect to p91 is dependent on the molar ratio between enzyme and DNA.
At molar excess of plasmid DNA, the rate-limiting step for relaxation of the total substrate population is the enzyme-DNA dissociation rate (21) . When changing the molar ratio between enzyme and DNA to excess of enzyme, the majority of DNA molecules become occupied by at least one enzyme molecule. In consequence, enzyme-DNA dissociation is no longer rate-limiting for relaxation. In this context, our results suggest that deleting the N-terminal domain of human topo I increases the dissociation rate of the enzyme to yield a higher turnover number. This interpretation is further supported by the more distributive relaxation mode of p67 relative to p91 ( Fig. 2A , compare lanes 2-4 with lanes 8-10), where the truncated enzyme appears to leave its substrate after removing only a few supercoils at a time. At the conditions used the relaxation mode of full-length topo I is known to be highly processive, going through multiple rounds of relaxation before dissociating from its substrate (22, 23) . Our data with p91
are consistent with this expectation. The relatively low relaxation activity of p67 at molar excess of enzyme (Fig. 2B ) may be explained in two ways. Either it reflects a slower catalysis of p67 relatively to p91 or a lower DNA affinity of p67 and a consequent reduction in the percentage of DNA bound enzyme at a given time. The two enzymes were incubated with supercoiled pBR322 at various concentrations of NaCl and the resulting products analyzed by gel electrophoresis. The amount of supercoiled pBR322 remaining after incubation with topo I was quantified and the relaxation activity plotted as a function of the salt concentration (Fig. 3A) . The p67 topo I showed a significantly lower salt optimum (25-75 mM NaCl) than p91, and was completely impaired in relaxation at 150 mM of NaCl. By contrast, the relaxation optimum for p91 was in the 100-150 mM NaCl range. These results are consistent with a lowered DNA affinity of p67. In agreement with this finding, an Nterminal fragment of human topo I (amino acids 1-218) binds DNA in a filter-binding assay ( topo I catalysis, the cleavage and ligation reactions of p67 and p91 were compared using synthetic suicide DNA substrates (16, 25, 26) . These substrates support cleavage while religation is temporarily prevented due to dissociation of a short oligonucleotide containing the 5´-OH end generated during cleavage (Fig. 4A, right The cleavage reactions of p67 and p91 were investigated by incubating the enzymes with the suicide substrate OL19/OL27 at 37°C. Fig. 4A shows the extent of covalent complex formation plotted as a function of time. The cleavage reactions for both enzymes were quite fast, being completed within the first 40 seconds of incubation and no significant difference between the two enzymes could be observed at these conditions. Note, however, that at low temperatures, the cleavage rates were markedly different for p67 and p91 (see below; Fig 7A) .
Involvement
To investigate intra-and intermolecular ligation, topo I was mixed with the appropriate suicide DNA substrate to obtain active cleavage complexes with the enzyme covalently attached at an internal (substrate OL19/OL27) or a terminal position (substrate OL22/OL25), respectively.
After incubation for 5 minutes at 37°C, the salt concentration was increased to 300 mM in order to prevent further cleavage and the appropriate ligator strands were added (5´-HO-dApdG for intramolecular ligation and OL32/OL33 for intermolecular ligation). Figs. 4B and 4C show the percentage of cleavage complexes converted to ligation products plotted as a function of the incubation time. As shown in Fig. 4C , the ability of p67 to mediate intermolecular ligation was severely compromised compared to p91, whereas the effect of deleting the N-terminal domain on intramolecular ligation was quite modest (no more than a two fold reduction in the initial reaction rate of p67 compared to p91; Fig 4B) . From the data in Fig. 4C , we estimate that the initial reaction rate for intermolecular ligation is at least 25-fold slower for p67 than for p91.
The most obvious difference between the two forms of ligation is their different The camptothecin sensitivities of p67 and p91 in relaxation were assayed in molar excess of enzyme over DNA in order to circumvent possible effects due to a slow dissociation rate and enzyme turnover in the presence of camptothecin. Note that camptothecin blocks religation and will thereby slow down all the subsequent steps of topo I catalysis. However, first it was necessary to slow down the reaction rate, which is too fast under standard conditions employing 5 mM MgCl 2 at 37°C (see Fig. 2B ) in order for the inhibition by camptothecin to be measured accurately. We found that excluding MgCl 2 from the reaction buffer slows down the reactions of both p67 and p91 sufficiently (compare Figs. 5 and 2) (10,26,28-31). To obtain more physiologically relevant conditions, 75 mM NaCl, at which concentration the two enzymes show similar activities (see Fig. 3 ), was added to the reaction mixture. Thus, the effect of camptothecin (60 µM) was assayed at 37°C in the absence of MgCl 2 and presence of 75 mM NaCl (Fig. 5) .
The relaxation rate of p67 was practically unaffected by camptothecin (Fig. 5A , compare lanes 7-12 with lanes 1-6), whereas that of p91 was decreased approximately 16-fold by the drug (Fig.   5B , compare lanes 7-12 with lanes 1-6). The drug resistance of p67 in relaxation is not due to a lowered binding affinity of the drug since camptothecin was found to be equally competent in stabilizing cleavage complexes introduced by p67 or p91 on double-stranded DNA fragments (data not shown). Rather, the N-terminal domain is likely required in order for camptothecin to block DNA strand rotation. Truncated versions of human topo I consisting of amino acids 175-765 or 191-765 have previously been reported to retain camptothecin sensitivity in relaxation (9, 10, 14) . Thus, taken together the available data indicate that the peptide region spanning amino acids 191-206 is important for drug sensitivity in relaxation, which in turn implicates this region in the controlling of strand rotation.
Temperature sensitivity of p67. While optimizing conditions for assaying the camptothecin effect (Fig. 5) , we discovered a striking difference between p91 and p67 in their sensitivity to low temperatures (Fig. 6) . The two enzyme forms were roughly equally active at 37°C.
However, at 0°C the relaxation rate of p91 dropped approximately 64-fold relative to that at 37°C (compare lanes 22-24 of Fig. 6A with lanes 10-12 of Fig. 6B ), while the corresponding activity drop for p67 was much higher, leaving the enzyme almost inert in relaxation ( Fig. 6A   lanes 2-12) . At 45°C, the relaxation activities of p67 and p91 were comparable (data not shown), as was the case at 37°C.
The cold sensitivity of p67 could be due to a conformational change leaving the enzyme completely inactive at 0°C or any single one of the catalytic steps could be defective. In order to investigate these possibilities, the cleavage and ligation reactions were analyzed separately at 0°C. Fig. 7A shows that the initial rate of cleavage by p67 at 0°C was decreased approximately 11-fold relative to p91, while there was no significant difference between the ligation rates of p67 and p91 at 0°C (Fig. 7B) . These experiments show that p67 is capable of catalyzing transesterification at 0°C, indicating that the active site of the enzyme is competent in transesterification chemistry even at low temperatures. The reduced ability of p67 to mediate strand cleavage may therefore rather be due to defects in the catalytic steps prior to cleavage such as DNA binding and/or in bringing the enzyme-DNA complex into a proper conformation for cleavage.
DISCUSSION
Although divergent in amino acid sequence, the N-terminal domain has been preserved through evolution as a highly basic region in all cellular type IB topoisomerases (32). In human topo I, a number of nuclear localization sequences, phosphorylation sites, and protein interaction sites have been mapped to the N-terminal domain (11, (32) (33) (34) (35) (36) . These diverse features are suggestive of multiple modes of topo I regulation in vivo. However, the N-terminal domain has long been thought to contribute little to the topo I enzyme activity per se. Here we describe for the first time a significant modulation of in vitro DNA relaxation mediated by residues within this domain.
The salient findings from our present work may be briefly summarized as follows. In the 
